← Back to Search

Intervention Group for Diabetes

N/A
Recruiting
Led By Harry Prapavessis, PhD
Research Sponsored by Western University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at week 12.
Awards & highlights
No Placebo-Only Group

Summary

This trial will help adults with type 2 diabetes meet guidelines on how much they should move in a day.

Eligible Conditions
  • Diabetes
  • Type 2 Diabetes
  • Sedentary Lifestyle
  • Acute Lymphoblastic Leukemia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at week 12.
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at week 12. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Objectively measured total sedentary behaviour
Self-reported total sedentary behaviour
Secondary study objectives
Objective sedentary behaviour break duration
Objective sedentary behaviour break frequency
Overall experience of the intervention
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
* Participants in the intervention group will be asked to wear an ACTIVPAL4 at week 0, 5, and 11. * Participants in the intervention group will be asked to fill out questionnaires assessing key variable (demographics, sedentary behaviour, and quality of life) on the SEMA3 app at week 0, 2, 4, 6, and 12. * Participants in the intervention group will receive a one-on-one behavioural counselling session online through zoom at week 0 to create personalized action plans and coping strategies to reduce and break up sedentary behaviour. The participant will update these action plans and coping strategies at the end of week 2 and 4 on the SEMA3 app. * Participants in the intervention group will receive tailored text messages the day after receiving their one-on-one counselling session for a 6-week period. * Participants in the intervention will receive one-on-one qualitative interview on zoom at week 6 to explore participants overall experience engaging in the intervention.
Group II: Control GroupActive Control1 Intervention
* Participants in the control group will be asked to wear an ACTIVPAL4 at week 0, 5, and 11. * Participants in the control group will be asked to fill out questionnaires assessing key variable (demographics, sedentary behaviour, and quality of life) on the SEMA3 mobile app at week 0, 2, 4, 6, and 12.

Find a Location

Who is running the clinical trial?

Western UniversityLead Sponsor
29 Previous Clinical Trials
128,679 Total Patients Enrolled
1 Trials studying Diabetes
30 Patients Enrolled for Diabetes
Harry Prapavessis, PhDPrincipal InvestigatorWestern University
8 Previous Clinical Trials
1,205 Total Patients Enrolled
2 Trials studying Diabetes
74 Patients Enrolled for Diabetes
~17 spots leftby Nov 2025